AlphaFold predicted structure
MT-ND2 · P03891

Mean pLDDT
95.1/ 100
Very high
347 residues
Confidence breakdown
- Very high(≥ 90)94%
- Confident(70–90)6%
- Low(50–70)0%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Likely inborn error of metabolism
MITOCHONDRIALMitochondrial disorders
MITOCHONDRIALUndiagnosed metabolic disorders
MITOCHONDRIALOptic neuropathy
MITOCHONDRIALAlbinism or congenital nystagmus
MITOCHONDRIALInfantile nystagmus
MITOCHONDRIALChildhood onset dystonia, chorea or related movement disorder
MITOCHONDRIALLeber hereditary optic neuropathy
mitochondrial disease
Leigh syndrome
mitochondrial complex I deficiency
type 2 diabetes mellitus
mitochondrial non-syndromic sensorineural hearing loss
diabetes mellitus
MELAS syndrome
Mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure
MERRF syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
NADH-ubiquinone oxidoreductase chain 2
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:16996290). Essential for the catalytic activity and assembly of complex I (PubMed:16996290)
Curated MONDO disease pages that list MT-ND2 among their top associated genes.
MT-ND2 · P03891

Mean pLDDT
95.1/ 100
Very high
347 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0